This blog is closed to new posts due to inactivity. The post remains here as part of the network’s archive of useful research information. We hope you'll join the conversation by posting to an open topic or starting a new one.
 
The United States National Center for Advancing Translational Sciences (NCATS) is announcing an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program.
The TRND program performs preclinical and early clinical development of new drugs for rare and neglected tropical diseases, and develops new technologies and paradigms to improve the efficiency of therapeutic development for these disorders. TRND seeks collaborative partnerships with academic laboratories, not-for-profit organizations, and for-profit companies. This is not a grant program, and no extramural funds will be provided.
Please visit the TRND website (http://www.ncats.nih.gov/trnd.html) and the related NIH Guide Notice (http://grants.nih.gov/grants/guide/notice-files/NOT-TR-13-007.html) for complete details regarding program scope, eligibility, and application process.
Letters of Intent are due no later than September 16, and full proposals must be submitted by September 30.